Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 12Myeloid 12Plasma cell 10Lymphoid 10Sarcoma 8Classical hematology 6Dermatologic 5Genitourinary 2Other neoplasm 1Gynecologic 1CNS 1Breast 1

Conditions

Neuroblastoma 8Recurrence 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neuroectodermal Tumors, Primitive, Peripheral 3Myelodysplastic Syndromes 3Lymphoma 3Leukemia 3Burkitt Lymphoma 3Sarcoma 2Rhabdomyosarcoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Dendritic Cell Sarcoma, Interdigitating 2Wilms Tumor 1Vasculitis, Central Nervous System 1Testicular Neoplasms 1Stiff-Person Syndrome 1Rhabdoid Tumor 1Rasmussen subacute encephalitis 1Primary Myelofibrosis 1Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1

Interventions

Flow Cytometry 5Psychiatric Rehabilitation 3Polymerase Chain Reaction 3Therapeutics 2Ondansetron 2Methylprednisolone 2Immunologic Techniques 2Fentanyl 2Early Intervention, Educational 2Dexamethasone 2Calcium Dobesilate 2Aprepitant 2Amplified Fragment Length Polymorphism Analysis 2Alemtuzumab 2thymoglobulin 1liposomal amphotericin B 1dexamethasone acetate 1dexamethasone 21-phosphate 1Voriconazole 1Valacyclovir 1Tacrolimus 1Sugars 1Stem Cell Transplantation 1Rituximab 1Prednisone 1Positron-Emission Tomography 1Pentetic Acid 1Pemetrexed 1Oxycodone 1Observation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pdgfra-Associated Chronic Eosinophilic Leukemia × Antilymphocyte Serum × CNS × Clear all
NCT00617929 2017-12-28

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
12 enrolled 12 charts
BreastCNSGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Carcinoma, Ovarian Epithelial, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Wilms Tumor, Neuroblastoma, Recurrence, Rhabdomyosarcoma, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡